miR106b regulates retinoblastoma Y79 cells through Runx3. 2017

Ge Yang, and Yang Fu, and Luxi Zhang, and Xiaoyan Lu, and Qiuming Li
Department of Ophthalmology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, P.R. China.

MicroRNAs are increasingly recognized as important regulators of cancer. The aim of the present study was to investigate the role of miR-106b in the regulation of Y79 retinoblastoma. Y79 cells were transfected with antisense oligonucleotides (ASO) against miR-106b (ASO-miR-106b) or ASO-control. After transfection, the levels of miR-106b were monitored with real-time PCR (RT-PCR). The effects of ASO-miR-106b transfection on cell viability was evaluated by Cell Counting Kit-8 (CCK-8) analysis at 24, 48 and 72 h after transfection. Subsequently, the cells were stained with Annexin V-FITC and propidium iodide (PI) and subjected to flow cytometry to assess cell apoptosis. Transwell assay was used to analyze cell migration. Changes in Runt-related transcription factor 3 (Runx3) mRNA and proteins levels were also evaluated. miR-106b was downregulated by ASO-miR-106b at 48 and 72 h after transfection, accompanied by a decrease in cell viability and proliferation, as well as an increase in cell apoptosis. Transwell analysis indicated that cells treated with ASO-miR-106b exhibited significantly lower cell migratory abilities. The mRNA and protein level of Runx3 were upregulated after transfection. These results demonstrated that suppression of miR-106b inhibited Y79 cell proliferation and migration. The upregulation of Runx3 after miR-106b suppression ascertained that Runx3 is a tumor-suppressor in retinoblastoma and is a target of miR-106b.

UI MeSH Term Description Entries
D002465 Cell Movement The movement of cells from one location to another. Distinguish from CYTOKINESIS which is the process of dividing the CYTOPLASM of a cell. Cell Migration,Locomotion, Cell,Migration, Cell,Motility, Cell,Movement, Cell,Cell Locomotion,Cell Motility,Cell Movements,Movements, Cell
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012175 Retinoblastoma A malignant tumor arising from the nuclear layer of the retina that is the most common primary tumor of the eye in children. The tumor tends to occur in early childhood or infancy and may be present at birth. The majority are sporadic, but the condition may be transmitted as an autosomal dominant trait. Histologic features include dense cellularity, small round polygonal cells, and areas of calcification and necrosis. An abnormal pupil reflex (leukokoria); NYSTAGMUS, PATHOLOGIC; STRABISMUS; and visual loss represent common clinical characteristics of this condition. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, p2104) Glioblastoma, Retinal,Glioma, Retinal,Neuroblastoma, Retinal,Eye Cancer, Retinoblastoma,Familial Retinoblastoma,Hereditary Retinoblastoma,Sporadic Retinoblastoma,Cancer, Retinoblastoma Eye,Cancers, Retinoblastoma Eye,Eye Cancers, Retinoblastoma,Familial Retinoblastomas,Glioblastomas, Retinal,Gliomas, Retinal,Hereditary Retinoblastomas,Neuroblastomas, Retinal,Retinal Glioblastoma,Retinal Glioblastomas,Retinal Glioma,Retinal Gliomas,Retinal Neuroblastoma,Retinal Neuroblastomas,Retinoblastoma Eye Cancer,Retinoblastoma Eye Cancers,Retinoblastoma, Familial,Retinoblastoma, Hereditary,Retinoblastoma, Sporadic,Retinoblastomas,Retinoblastomas, Familial,Retinoblastomas, Hereditary,Retinoblastomas, Sporadic,Sporadic Retinoblastomas
D015972 Gene Expression Regulation, Neoplastic Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control of gene action in neoplastic tissue. Neoplastic Gene Expression Regulation,Regulation of Gene Expression, Neoplastic,Regulation, Gene Expression, Neoplastic
D016376 Oligonucleotides, Antisense Short fragments of DNA or RNA that are used to alter the function of target RNAs or DNAs to which they hybridize. Anti-Sense Oligonucleotide,Antisense Oligonucleotide,Antisense Oligonucleotides,Anti-Sense Oligonucleotides,Anti Sense Oligonucleotide,Anti Sense Oligonucleotides,Oligonucleotide, Anti-Sense,Oligonucleotide, Antisense,Oligonucleotides, Anti-Sense
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines
D050677 Core Binding Factor Alpha 3 Subunit A transcription factor that dimerizes with the cofactor CORE BINDING FACTOR BETA SUBUNIT to form core binding factor. It contains a highly conserved DNA-binding domain known as the runt domain. AML2 Protein,Acute Myeloid Leukemia 2 Protein,CBFA3 Protein,Core-Binding Factor Alpha 3 Protein,PEBP2A3 Protein,Runt Domain Transcription Factor AML-2,Runt-Related Transcription Factor 3 Protein,Runx3 Protein,Core Binding Factor Alpha 3 Protein,Runt Related Transcription Factor 3 Protein
D019572 Retinal Neoplasms Tumors or cancer of the RETINA. Cancer of the Retina,Cancer, Retinal,Neoplasms, Retinal,Retinal Cancer,Retinal Tumors,Tumors, Retinal,Cancers, Retinal,Neoplasm, Retinal,Retinal Cancers,Retinal Neoplasm,Retinal Tumor,Tumor, Retinal
D020413 3' Untranslated Regions The sequence at the 3' end of messenger RNA that does not code for product. This region contains transcription and translation regulating sequences. 3'UTR,3' UTR,3' Untranslated Region,3' UTRs,3'UTRs,Region, 3' Untranslated,Regions, 3' Untranslated,UTR, 3',UTRs, 3',Untranslated Region, 3',Untranslated Regions, 3'

Related Publications

Ge Yang, and Yang Fu, and Luxi Zhang, and Xiaoyan Lu, and Qiuming Li
September 1983, Journal of neurochemistry,
Ge Yang, and Yang Fu, and Luxi Zhang, and Xiaoyan Lu, and Qiuming Li
May 1995, Biochemical and biophysical research communications,
Ge Yang, and Yang Fu, and Luxi Zhang, and Xiaoyan Lu, and Qiuming Li
May 1999, Neuroscience letters,
Ge Yang, and Yang Fu, and Luxi Zhang, and Xiaoyan Lu, and Qiuming Li
November 2000, Neuroscience letters,
Ge Yang, and Yang Fu, and Luxi Zhang, and Xiaoyan Lu, and Qiuming Li
January 2018, International journal of clinical and experimental pathology,
Ge Yang, and Yang Fu, and Luxi Zhang, and Xiaoyan Lu, and Qiuming Li
May 2014, Clinical and experimental pharmacology & physiology,
Ge Yang, and Yang Fu, and Luxi Zhang, and Xiaoyan Lu, and Qiuming Li
July 1989, Journal of neurochemistry,
Ge Yang, and Yang Fu, and Luxi Zhang, and Xiaoyan Lu, and Qiuming Li
March 1992, The Journal of comparative neurology,
Ge Yang, and Yang Fu, and Luxi Zhang, and Xiaoyan Lu, and Qiuming Li
January 1993, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research,
Ge Yang, and Yang Fu, and Luxi Zhang, and Xiaoyan Lu, and Qiuming Li
January 1998, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine,
Copied contents to your clipboard!